Business
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22 ...
About this update from Aurora Cannabis Inc.
[{"type":"text","content":"\n\n\n\n Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n NASDAQ | TSX: ACB\n \n\n\n\n Canada's\n \n Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market\n \n\n\n\n\n EDMONTON, AB\n \n\n ,\n \n\n June 5, 2025\n \n\n /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company's subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22% THC potency creates a greater range of treatment options available to prescribers.\n \n\n\n\n\n\n\n\n\n \"Expanding our portfolio in the value segment in\n \n Australia\n \n reinforces our commitment to meet increasingly diversified patient needs with accessible, high-quality medical cannabis options,\" said\n \n Andre Jerome\n \n , Executive Vice President of Global Business Development at Aurora. \"As a global leader in medical cannabis, we're proud to offer a diverse range of products that reflect both local demand and our dedication to innovation worldwide.\"\n \n\n IndiMed remains one of the most prescribed medical cannabis brands for patients in\n \n Australia\n \n . The two new cultivars available include:\n \n\n\n IndiMed TEMPO 22 | Lemon Laser – Sativa, 22% THC, <1% CBD, Dried Cannabis (15g)\n \n\n IndiMed TEMPO 22 | Pickled Petrol – Indica, 22% THC, <1% CBD, Dried Cannabis (15g)\n \n\n\n\n Aurora's continued focus on international growth and deep commitment to providing patients with innovative products and expanded access enables the company to maintain its global leadership position.\n \n\n\n MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality and proudly meeting all TGA-GMP standards. For further information about the company's offerings, d...